椎体后凸成形术市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、适应症、最终用户、地区和竞争细分，2019-2029F

2023 年，全球椎体后凸成形术市场价值为6.7025 亿美元，预计在预测期内将出现令人印象深刻的成长，到2029 年复合年增长率为6.04%。成形术的手术治疗用于延长和稳定脊椎压力性骨折。它包括将一种特殊的水泥注入脊柱，并用气球状的小工具为手术腾出空间。椎体后凸成形术是一种椎体成形术，可以减轻疼痛并恢復受损椎骨的高度。球囊椎体后凸成形术已经使用了二十多年，治疗了超过一百万例骨折。临床研究表明，球囊后凸成形术与非手术治疗相比，能有效恢復椎体水平，增强椎体变形。近年来，中国、美国、德国、韩国、义大利等国际上积极推广椎体后凸成形术治疗骨科疾病。

市场概况
预测期	2025-2029
2023 年市场规模	67025万美元
2029 年市场规模	82688万美元
2024-2029 年复合年增长率	6. 04%
成长最快的细分市场	球囊导管
最大的市场	北美洲

主要市场驱动因素

骨质疏鬆症和关节炎的盛行率增加

基于椎体后凸成形术的研究与开发不断发展

全球老年人口的增加

椎体后凸成形术设备与技术的创新

主要市场挑战

程序成本高

发展中地区的进入有限

主要市场趋势

术后成功率

脊椎损伤病例激增

细分市场洞察

产品洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：全球椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品（球囊导管、骨骼接入装置、骨水泥应用产品、骨水泥、骨水泥混合系统、仪器）
  • 依应用（脊椎排列恢復、脊椎骨折、脊椎后凸）
  • 依适应症（骨质疏鬆症、其他）
  • 按最终使用者（医院和诊所、门诊手术中心、其他）
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 5 章：北美椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按指示
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 6 章：欧洲椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按指示
  • 按最终用户
  • 按国家/地区

第 6 章：3 欧洲：国家分析

• 法国椎体后凸成形术市场展望
  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按申请
    • 按指示
    • 按最终用户
• 德国椎体后凸成形术市场展望
  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按申请
    • 按指示
    • 按最终用户
• 英国椎体后凸成形术市场展望
  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按申请
    • 按指示
    • 按最终用户
• 义大利椎体后凸成形术市场展望
  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按申请
    • 按指示
    • 按最终用户
• 西班牙椎体后凸成形术市场展望
  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按申请
    • 按指示
    • 按最终用户

第 7 章：亚太地区椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按指示
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第 8 章：南美洲椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按指示
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲椎体后凸成形术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按指示
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非椎体后凸成形术

第 10 章：市场动态

• 司机
• 挑战

第 11 章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最近的发展

第 12 章：大环境分析

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量

第 13 章：4。客户的力量

• 替代产品的威胁

第14章：竞争格局

• Stryker Corporation
• Medtronic plc
• Smith + Nephew Plc
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC (Halma plc)
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Kyphoplasty Market was valued at USD 670.25 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.04% through 2029. A surgical treatment called kyphoplasty is utilized to extend and stabilize spinal pressure fractures. It includes infusing a particular cement into the spine and making space for the procedure with a balloon like gadget. Kyphoplasty is a type of vertebroplasty that reduces pain and restores the height of a damaged vertebra. The balloon kyphoplasty method has been utilized for more than twenty years, treating over one million fractures. Clinical studies have shown that balloon kyphoplasty, contrasted with non-surgical procedures, effectively restores vertebral body level, and enhances vertebral body deformation. China, USA, Germany, Korea, and Italy are a some of the leading nations across the world which are effectively promoting the utilization of kyphoplasty in treatment of orthopedic diseases during recent years.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 670.25 Million
Market Size 2029	USD 826.88 Million
CAGR 2024-2029	6. 04%
Fastest Growing Segment	Balloon Catheters
Largest Market	North America

Key Market Drivers

Growth in Prevalence of Osteoporosis & Arthritis

Osteoporosis is a bone disease that develops when bone mineral thickness and bone mass declines, or when the structure and strength of bone changes. This can further prompt a decrease in bone strength that can enhance the chances of fractures. Hormonal changes, lack of vitamin D, and medical conditions such as gastrointestinal illnesses, rheumatoid joint inflammation, and specific kinds of cancer are the essential causes of osteoporosis which are profoundly predominant across the world. As per the report published by BioMed Central, it has been observed that 26.3% of entire Japanese population are impacted by osteoporosis in either other hip or spine followed by 21% of population in United States of America, 14.3% of German population, 9.9% of French population, 9.7% of Italian population, 7.8% population in United Kingdom, 6.3% of Spanish population, 2.6% of Canadian population, and 2% of population in Australia. Kyphoplasty has been designed to address the kyphotic deformation and assist with realigning the spine. It includes the percutaneous placement of an inflatable bone pack into a vertebral body. Restoration of VB level and kyphosis correction is accomplished by expansion of the bone pack with fluid. After deflation, a cavity is created that helps in cement application which further enhances the management of osteoporosis. Another orthopedic disease which is emerging with a lucrative rate across the world is arthritis. Arthritis is a typical problem that influences the joints. It can cause pain and inflammation, making it hard to move or remain dynamic. Recent report published by Centers for Disease Control and Prevention stated that the greater ratio of US adults (57.3%) with joint pain are of working age (18 to 64 years). Arthritis can restrict the kind of work they can do or hold them back from working by any means. As a matter of fact, 8 million working-age grown-ups report that their capacity to work is restricted due to joint pain. Balloon kyphoplasty is considered to be an effective procedure for reducing joint pain in patients of arthritis which is further anticipated to contribute to the impressive growth of Global KypKyphoplasty Markethoplasty market in the forecast period.

Growing Research & Development Based on Kyphoplasty

Increase in research and development based on kyphoplasty coupled with clinical trials are attributed to register a lucrative growth to Global Kyphoplasty Market in upcoming years. In recent years, different procedures have been developed to treat vertebral pressure cracks for instance, expand kyphoplasty (BKP) and TIVADs. In 2019, Stryker published a clinical report pointed toward supporting a noninferiority finding for its Spine Jack TIVAD gadget. The essential target of the SAKOS clinical review was to compare pain, disability, and unfavorable events through the 12-month period following a vertebral increase methodology with either a SpineJack or a Medtronic Kypho balloon kyphoplasty gadget. The research team of Medtronic were expecting to explore the potential effect of utilizing a directional cannula to put the BKP balloons into a superior position. To accomplish these objectives, Medtronic funded to a limited extent a lab concentrates on utilizing practical spine units from human corpses. Five osteoporotic female human cadaver thoracolumbar spines were dissected into 30 two-functional spine units, and the anterior height of the vertebrae was reduced by 25% to create vertebral wedge compression fractures. Post-fracture, medical procedure was performed on the two-utilitarian spine units utilizing the three different reciprocal strategies. Post-medical procedure, cyclic stacking was carried out on each two¬ useful spine unit utilizing loads that were illustrative of walking (600N), standing up or sitting down (850N), and lifting a 5-to-10-kilogram weight from the floor (1250N). The review tracked down each of the three medicines (BKP, BKP w/Kyphon Assist, and TIVAD) can reestablish level in basically the same manner after a vertebral pressure break. At least 94% of the height was restored with each treatment.

Increase in Worldwide Geriatric Population

Growth in geriatric population across the world and their vulnerability towards certain orthopedic diseases such as osteoporosis and arthritis are also attributed to register an impressive growth to Global Kyphoplasty Market in the forecast period. According to the data released by Population Reference Bureau, it has been noticed that China has the greatest population of senior residents, with roughly 166.37 million people over the age of 65 out of the total population. India follows with 84.9 million people, the US with 52.76 million people, Japan with 35.58 million people, and the Russian Federation with 21.42 million people over 65 years of age out of the absolute population. As the incidences of osteoporosis is rising across the world, the National Osteoporosis Foundation have accessed the prevalence to be around 9 million adults in the US and an extra 43 million with low bone mass, putting all at expanded risk for vertebral pressure cracks. Vertebral compression fractures can cause significant morbidities both acute and chronic, prompting practical constraints, constant pain, loss of autonomy, and respiratory difficulties. Hence to control the prevalence of such problems, demand of kyphoplasty is also increasing around the world which is further supporting the market growth.

Innovations in Kyphoplasty Devices & Techniques

Innovations in kyphoplasty devices and techniques are significantly driving the demand for kyphoplasty procedures globally. Kyphoplasty is a minimally invasive surgical procedure used to treat vertebral compression fractures (VCFs), a common consequence of osteoporosis and trauma. Recent advancements in kyphoplasty technology have led to the development of more sophisticated devices and techniques aimed at improving procedural outcomes and patient safety. These innovations include the introduction of new bone cement formulations with enhanced viscosity and handling characteristics, allowing for better vertebral augmentation and fracture stabilization. Advancements in imaging technology, such as fluoroscopy and intraoperative navigation systems, enable more precise placement of kyphoplasty instruments and cement delivery, reducing the risk of complications and optimizing patient outcomes. Novel surgical approaches and instrumentation techniques, such as balloon-assisted kyphoplasty and vertebral body stenting, offer alternatives for treating complex fractures and improving spinal alignment. As a result of these innovations, kyphoplasty procedures have become more effective, efficient, and accessible, driving increased demand globally. As the aging population grows and osteoporosis-related fractures become more prevalent, the demand for kyphoplasty is expected to continue rising, making these innovations indispensable in meeting the evolving needs of patients with vertebral compression fractures.

Key Market Challenges

High Procedure Costs

High procedure costs are a significant factor contributing to the decrease in demand for kyphoplasty globally. Despite its efficacy and benefits, kyphoplasty procedures can be expensive, placing a financial burden on patients, healthcare systems, and insurance providers. The costs associated with kyphoplasty include hospital fees, surgeon fees, anesthesia costs, imaging expenses, and the price of specialized equipment and materials used during the procedure. Postoperative care and rehabilitation further add to the overall expense. The high costs of kyphoplasty may deter some patients from pursuing the procedure, particularly those with limited financial resources or inadequate insurance coverage. Healthcare systems and insurance providers may face challenges in covering the expenses associated with kyphoplasty for all eligible patients, leading to disparities in access to care based on financial considerations. As a result, the high procedure costs associated with kyphoplasty contribute to a decrease in demand globally, limiting the number of patients able to benefit from this effective treatment option for vertebral compression fractures. Efforts to address cost barriers through price transparency, reimbursement reforms, and cost-effective healthcare delivery models are essential to ensure equitable access to kyphoplasty procedures and improve outcomes for individuals suffering from spinal fractures globally.

Limited Access in Developing Regions

Limited access to kyphoplasty procedures in developing regions is a significant factor contributing to the decrease in demand for this treatment option globally. While kyphoplasty offers effective relief for vertebral compression fractures (VCFs), access to this procedure remains constrained in many developing regions due to various factors. These include a lack of specialized healthcare facilities equipped to perform kyphoplasty, shortages of skilled healthcare professionals trained in the procedure, and inadequate healthcare infrastructure to support postoperative care and rehabilitation. Financial constraints and limited insurance coverage further hinder access to kyphoplasty for patients in developing regions, as the procedure's costs can be prohibitive for individuals with low incomes or inadequate healthcare coverage. Logistical challenges such as transportation barriers and geographic isolation may exacerbate the difficulty in accessing kyphoplasty services, particularly for individuals residing in rural or remote areas. As a result, the limited availability and accessibility of kyphoplasty procedures in developing regions significantly decrease the demand for this treatment option globally, underscoring the urgent need for investment in healthcare infrastructure, capacity-building initiatives, and equitable healthcare policies to address disparities in access to essential surgical interventions for spinal fractures.

Key Market Trends

Post-Surgery Success Rates

The increasing demand for kyphoplasty procedures globally is closely tied to the impressive post-surgery success rates associated with this minimally invasive spinal surgery. Kyphoplasty is renowned for its ability to swiftly alleviate pain, restore vertebral height, and improve spinal stability in patients suffering from vertebral compression fractures (VCFs), often caused by osteoporosis or trauma. The procedure's success is evident in its high rates of pain relief and functional improvement, with many patients experiencing immediate relief following surgery. Kyphoplasty has demonstrated long-term benefits, including reduced disability and improved quality of life for individuals with VCFs. The minimally invasive nature of kyphoplasty translates to shorter hospital stays, quicker recovery times, and lower rates of postoperative complications compared to traditional open spinal surgeries, further enhancing patient satisfaction and outcomes. As a result, the exceptional success rates associated with kyphoplasty have garnered widespread recognition and acceptance among patients and healthcare providers globally, driving the demand for this effective treatment option for vertebral compression fractures. The growing understanding of the procedure's efficacy and its ability to deliver positive outcomes continues to fuel the demand for kyphoplasty procedures worldwide, making it an increasingly sought-after solution for individuals suffering from VCFs.

Surge in Spinal Injury Cases

The surge in spinal injury cases worldwide is significantly increasing the demand for kyphoplasty procedures globally. Spinal injuries can result from various causes, including traumatic accidents, falls, sports injuries, and osteoporosis-related vertebral compression fractures (VCFs). As the incidence of these injuries rises due to factors such as aging populations, increased participation in physical activities, and changes in lifestyle, the demand for effective treatment options like kyphoplasty has grown substantially. Kyphoplasty offers a minimally invasive approach to treating VCFs, providing rapid pain relief, stabilizing fractured vertebrae, and restoring vertebral height. This procedure not only helps patients regain mobility and functionality but also reduces the risk of long-term complications associated with untreated vertebral fractures, such as chronic pain, deformity, and decreased quality of life. The minimally invasive nature of kyphoplasty allows for shorter hospital stays, faster recovery times, and fewer postoperative complications compared to traditional open spinal surgeries, making it an attractive option for both patients and healthcare providers. Consequently, the surge in spinal injury cases has fueled the demand for kyphoplasty procedures globally, as individuals seek timely and effective solutions to manage their spinal fractures and improve their overall health and well-being.

Segmental Insights

Product Insights

Based on the product, in the global Kyphoplasty Market, Balloon Catheters have emerged as the dominant choice among medical professionals. These innovative devices play a crucial role in the kyphoplasty procedure by facilitating the restoration of height and shape to compressed vertebrae prior to the application of bone cement. With their exceptional reliability and effectiveness in creating a carefully crafted cavity within the vertebral body, Balloon Catheters ensure the even distribution of cement, resulting in improved outcomes for patients. This careful distribution of cement not only enhances the stability and structural integrity of the spine but also reduces the risk of complications.

Balloon Catheters are designed with precision and expertise, allowing for accurate placement and controlled inflation during the procedure. This level of control enables healthcare providers and specialists to tailor the treatment to each patient's specific needs, resulting in personalized and effective care. The remarkable performance and ability of Balloon Catheters to address the challenges of kyphoplasty have solidified their prominence in the market, making them the go-to option for healthcare providers and specialists worldwide. Their proven track record in enhancing patient outcomes and their widespread adoption in the medical community have further cemented their position as a reliable and trusted solution. As advancements in technology and medical research continue to drive innovation in the field of kyphoplasty, Balloon Catheters are expected to evolve further, offering even more precise and efficient solutions for patients. With their continuous development and growing acceptance, Balloon Catheters are set to play a pivotal role in shaping the future of kyphoplasty and improving the lives of individuals suffering from vertebral compression fractures.

Regional Insights

North America holds a dominating position in the Global Kyphoplasty Market. This is mainly attributed to the region's advanced healthcare infrastructure, which not only allows for the seamless implementation of innovative medical procedures but also ensures a high standard of patient care. The widespread acceptance and adoption of minimally invasive techniques have further propelled the growth of the market, as patients benefit not only from reduced recovery times but also from shorter hospital stays and improved overall outcomes. The presence of leading medical device companies in North America ensures access to cutting-edge technologies and expertise. These companies continuously invest in research and development, pushing the boundaries of medical innovation and driving the advancement of kyphoplasty procedures. As a result, healthcare providers in the region can offer patients the most up-to-date and effective treatment options available.

Another significant factor contributing to the growth of the Kyphoplasty Market in North America is the aging population. With the increasing number of elderly individuals in the region, the prevalence of spinal disorders, such as vertebral compression fractures, is on the rise. This has led to an increased demand for kyphoplasty procedures, as they provide a minimally invasive and effective solution for relieving pain, stabilizing fractures, and restoring spinal function. The dominance of North America in the Global Kyphoplasty Market can be attributed to its advanced healthcare infrastructure, widespread acceptance of minimally invasive techniques, presence of leading medical device companies, and the increasing demand for kyphoplasty procedures due to the aging population. These factors combined contribute to the continuous growth and expansion of the Kyphoplasty Market in North America, making it a key region in the field of spinal healthcare.

Key Market Players

Stryker Corporation

Medtronic plc

Smith + Nephew Plc

Microport Scientific Corporation

DePuy Synthes Companies

IZI Medical Products, LLC (Halma plc)

Merit Medical Systems, Inc.

Joline GmbH & Co. KG

Hensler Surgical Products LLC

Jiangsu Changmei Medtech Co., Ltd.

Report Scope:

In this report, the Global Kyphoplasty Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kyphoplasty Market, By Product:

Balloon Catheters Bone Access Devices Cement Application Products Bone Cement Cement Mixing System Instruments

Kyphoplasty Market, By Application:

Vertebral Alignment Restoration Spinal Fractures Kyphosis

Kyphoplasty Market, By Indication:

Osteoporosis Others

Kyphoplasty Market, By End User:

Hospitals & Clinics Ambulatory Surgical Centres Others

Kyphoplasty Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kyphoplasty Market.

Available Customizations:

Global Kyphoplasty market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Kyphoplasty Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing System, Instruments)
  • 4.2.2. By Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis)
  • 4.2.3. By Indication (Osteoporosis, Others)
  • 4.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2023)
• 4.3. Market Map

5. North America Kyphoplasty Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Application
  • 5.2.3. By Indication
  • 5.2.4. By End User
  • 5.2.5. By Country
• 5.3. North America: Country Analysis
  • 5.3.1. United States Kyphoplasty Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By Indication
      • 5.3.1.2.4. By End User
  • 5.3.2. Mexico Kyphoplasty Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.1.1. By Product
      • 5.3.2.1.2. By Application
      • 5.3.2.1.3. By Indication
      • 5.3.2.1.4. By End User
  • 5.3.3. Canada Kyphoplasty Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By Indication
      • 5.3.3.2.4. By End User

6. Europe Kyphoplasty Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Indication
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3 Europe: Country Analysis
  • 6.3.1. France Kyphoplasty Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By End User
  • 6.3.2. Germany Kyphoplasty Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By End User
  • 6.3.3. United Kingdom Kyphoplasty Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By End User
  • 6.3.4. Italy Kyphoplasty Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Indication
      • 6.3.4.2.4. By End User
  • 6.3.5. Spain Kyphoplasty Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Indication
      • 6.3.5.2.4. By End User

7. Asia-Pacific Kyphoplasty Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Indication
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Asia-Pacific: Country Analysis
  • 7.3.1. China Kyphoplasty Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By End User
  • 7.3.2. India Kyphoplasty Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By End User
  • 7.3.3. South Korea Kyphoplasty Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By End User
  • 7.3.4. Japan Kyphoplasty Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By End User
  • 7.3.5. Australia Kyphoplasty Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By End User

8. South America Kyphoplasty Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Indication
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Kyphoplasty Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By End User
  • 8.3.2. Argentina Kyphoplasty Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By End User
  • 8.3.3. Colombia Kyphoplasty Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By End User

9. Middle East and Africa Kyphoplasty Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Indication
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. Saudi Arabia Kyphoplasty Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Kyphoplasty Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By End User
  • 9.3.3. South AfricaKyphoplasty Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Merger & Acquisition (If Any)
• 11.2. Product Launches (If Any)
• 11.3. Recent Developments

12. PESTLE Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers

13.4 . Power of Customers

• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Stryker Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Medtronic plc
• 14.3. Smith + Nephew Plc
• 14.4. Microport Scientific Corporation
• 14.5. DePuy Synthes Companies
• 14.6. IZI Medical Products, LLC (Halma plc)
• 14.7. Merit Medical Systems, Inc.
• 14.8. Joline GmbH & Co. KG
• 14.9. Hensler Surgical Products LLC
• 14.10. Jiangsu Changmei Medtech Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer